Welcome to our dedicated page for TILRAY BRANDS news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on TILRAY BRANDS stock.
Tilray Brands Inc. (TLRY) maintains a dynamic presence in global cannabis markets through its medical research initiatives and consumer product innovations. This resource provides investors and industry observers with centralized access to verified corporate announcements, regulatory developments, and market analysis.
Users will find updates spanning earnings reports, international expansion efforts, and product portfolio enhancements, including developments in cannabis-infused wellness solutions. The curated selection enables stakeholders to track operational milestones across Tilray's pharmaceutical-grade production facilities and lifestyle brand divisions.
All content undergoes strict verification to ensure alignment with financial disclosure standards and industry regulations. Regular updates reflect Tilray's position as a GMP-certified producer serving medical markets in 20+ countries while expanding recreational offerings in emerging markets.
Bookmark this page for streamlined monitoring of Tilray's strategic initiatives, quality control advancements, and responses to evolving cannabis legislation worldwide.
Breckenridge Brewery, a Tilray Brands (NASDAQ: TLRY) subsidiary, has launched Spring Forward Grapefruit IPA, a new seasonal beer release. The -edition brew combines grapefruit and citrus flavors with hop-driven bitterness, featuring Amarillo, Cascade, and Citra hops.
The beer will be available from January through April 2025 in 6-pack bottles and on draft at select regional retailers. The packaging design showcases vibrant pinks, purples, and greens to reflect blooming seasons. Brewmaster Carl Heinz emphasizes the beer's refreshing character and year-round appeal.
Tilray Brands (TLRY) reported strong Q2 2025 financial results with notable growth across all business segments. Net revenue increased 9% year-over-year to $211 million, while gross profit rose 29% to $61 million. The company's beverage segment showed remarkable performance with a 36% revenue increase to $63 million.
The company reported a net loss of $(85) million, of which $75 million was comprised of non-cash items. Adjusted EBITDA was $9 million compared to $10 million in the prior year. Tilray announced Project 420, a $25 million synergy plan for its beverage business, with $17 million already achieved by Q2 end.
Key segment performance includes beverage alcohol gross margin increasing to 40%, cannabis net revenue at $66 million with 35% gross margin, distribution revenue of $68 million, and wellness segment growing 13% to $15 million. The company reaffirmed its fiscal year 2025 guidance of anticipated net revenues between $950 million and $1 billion.
Tilray Medical, through its German subsidiary Tilray Deutschland GmbH, has won a tender from Luxembourg's Ministry of Health and Social Security to supply medical cannabis flower to the country. This achievement reinforces Tilray's position in Europe's growing medical cannabis market and demonstrates the company's capability to consistently deliver high-quality medical cannabis products internationally.
According to Denise Faltischek, Chief Strategy Officer and Head of International, this repeat selection by Luxembourg validates the company's commitment to providing quality medical cannabis to patients worldwide.
Tilray Brands (Nasdaq: TLRY; TSX: TLRY) has rescheduled its second quarter fiscal 2024 earnings release from January 9 to January 10, 2025, before market open. The change is due to the closure of the SEC and U.S. stock markets on January 9 for the National Day of Mourning honoring former President Jimmy Carter.
The company will host a live conference call and audio webcast to discuss the results at 8:30 am Eastern Time on January 10. The financial results will cover the quarter ended November 30, 2024. Investors can access the webcast through Tilray's website investor section.
Tilray Brands (Nasdaq: TLRY; TSX: TLRY) has announced its expanded cannabis beverage portfolio in Canada, featuring products under three brands: Mollo, Solei, and XMG. The lineup includes various THC, CBD, and CBG-infused beverages with different cannabinoid concentrations and flavors.
Mollo Seltzers offers Blackberry flavor (10mg THC, 20mg CBG) with upcoming Wildberry Acai and Watermelon Lime variants. Solei's range includes sparkling beverages and cold brew teas with varying THC/CBD/CBG combinations. XMG features two product lines: XMG+ with caffeine-infused options and XMG Zero with zero-calorie sodas containing 10mg THC.
Tilray Brands (Nasdaq: TLRY; TSX: TLRY) introduces its non-alcoholic beverage portfolio for the new year, featuring multiple brands. Liquid Love offers sparkling waters with electrolytes and B-vitamins in four flavors, donating five cents per sale to water conservation. Herb & Bloom and Happy Flower both feature hemp-derived Delta-9 THC (5mg per can) in various mocktail flavors. Runner's High presents alcohol-free craft brews in Golden Wheat, Raspberry Wheat, and Dark Chocolate varieties. Montauk Brewing Company debuts its first N.A. IPA with less than 0.5% ABV, featuring Citra, Mosaic, and Cryo hops.
SweetWater Brewing Company, the Southeast's largest craft brewer and a Tilray Brands (NASDAQ: TLRY) subsidiary, announces its 28th Anniversary Bash featuring electronic jam band STS9 as headliner. The event is scheduled for February 22 at SweetWater's Atlanta brewery.
The celebration includes double sets by STS9, performances by Break Science, Marvel Years, Sneezy, and others, plus a Rock Poster Show featuring authentic band posters. Early Bird General Admission tickets are priced at $60, while KUSH VIP tickets cost $97, offering additional perks including complimentary drinks, VIP access, and exclusive viewing areas.
SweetWater's HoliBlaze promotion offers 25% off when purchasing Anniversary Party tickets together with SweetWater 420 Fest weekend passes, available until January 1.
Tilray Brands (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company, has announced it will release its second quarter fiscal 2025 financial results on January 9, 2025, before market open. The results will cover the period ended November 30, 2024. The company will host a live conference call and audio webcast at 8:30 a.m. Eastern Time to discuss the results, which will be accessible through the Investors section of Tilray's website.
Redecan Cannabis, a Tilray Brands (TLRY) brand, has expanded its 'Wrapped & Redee' Redees Hemp'd line with two new -edition genetics for the holiday season. The new offerings include Legendary Kush (Sativa) and Orange Cream Fuel (Indica), available in 20 x 0.4g packs containing ten pre-rolls of each strain.
The pre-rolls feature ultra-thin hemp paper and patented filter tips, made with hang-dried and precisely milled flower. Legendary Kush combines Larry OG and Legend OG genetics, offering earthy, citrus, and spicy notes. Orange Cream Fuel, derived from Jet Fuel Gelato and Orange Cookies, provides fruity and diesel undertones. Both products are available nationwide at authorized Canadian cannabis retailers.
Tilray Brands (Nasdaq: TLRY; TSX: TLRY) announced new product launches under its Good Supply cannabis brand for the holiday season. The lineup includes three major innovations: JUICED XTREME Resin Infused Pre-rolls featuring double infusion of full spectrum resin and naturally flavoured distillate in 0.6g cones; 2g 510 Vapes with double-distilled THC distillate and unique cannabinoid blend (1,000mg THC, 300mg CBG, 300mg CBD); and Monsters: 'The Grump' Holiday -Edition Pre-rolls containing 1,000mg THC in 2.38g of infused pre-rolls. Products will be available at select Canadian retailers with planned national expansion in the new year.
FAQ
What is the current stock price of TILRAY BRANDS (TLRY)?
What is the market cap of TILRAY BRANDS (TLRY)?
